Clinical Trials Logo

Spinocerebellar Ataxia Type 8 clinical trials

View clinical trials related to Spinocerebellar Ataxia Type 8.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03701399 Active, not recruiting - Clinical trials for Spinocerebellar Ataxias

Troriluzole in Adult Subjects With Spinocerebellar Ataxia

Start date: March 8, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy of Troriluzole (200mg once daily) versus placebo after 48 weeks of treatment in subjects with spinocerebellar ataxia (SCA).